Arrhythmotech LLC, an Indiana University startup company that is developing a new generation of cardio monitoring instruments, has been selected to make a poster presentation of its work on Wednesday, March 4, during the National Heart, Lung and Blood Institute’s (NHLBI) Regional Innovation Conference-Midwest in Columbus, Ohio.
NHLBI is a division of the National Institutes for Health (NIH). The Office of Translational Alliances and Coordination for NHLBI facilitates Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, and hosts such conferences twice a year. These events bring together small businesses, angel investors, venture capitalists, strategic partners and business leaders from the biotech, medical device and pharmaceutical industries. Attendees view presentations from NHLBI-funded companies, learn about changes in the SBIR/STTR program and other funding and cost-free resources for small businesses.
Arrhythmotech was launched in 2012 with the help of Indiana University Research and Technology Corp.’s Spin Up program. Last year, Arrhythmotech received a $212,634 STTR grant from NIH in support of neuECG, a device that records and processes both sympathetic nerve activity and electrocardiogram signals without entering the body. To date, no device allows simultaneous recording and processing in this manner. While several electrocardiogram technologies are non-invasive, detecting sympathetic nerve activity requires direct nerve contact.
Arrhythmotech’s co-founders are Peng-Sheng Chen and Shien-Fong Lin. Chen serves as division chief of the Krannert Institute of Cardiology and is the Medtronic Zipes Chair in Cardiology at the Indiana University School of Medicine in Indianapolis. Lin is a professor of medicine at the IU School of Medicine and director of the Institute for Biomedical Engineering at National Chiao Tung University in Taiwan. The pair have collaborated in arrhythmia research for more than 15 years.
Leave a Reply